Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01311596 · ClinicalTrials.gov registry record

Show Me to Help Me

A clinical trial of Autism, sponsored by Akron Children's Hospital.

Completed
Registry status
83
Enrollment target
1
Study location

NCT01311596: Completed study of Autism, sponsored by Akron Children's Hospital.

NCT01311596 is a study of Autism that has completed, run by Akron Children's Hospital. The registered enrollment target is 83 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01311596, a study of Autism, has completed, sponsored by Akron Children's Hospital.

COMPLETED
Registry status
83 participants
Enrollment target
1
Study location

Study Summary

This cohort observation, randomized controlled trial is intended to provide data that icons and non-verbal communication improve communication and cooperation with children with Autism/communication delay and aid in the transition to an unfamiliar environment. It would lay the foundation for future studies and practices of using icons and pictures for the whole office visit to enhance communication between the patient and physician/nurse/medical staff and cooperation of the patient. 1. Use icons during triage/check in process to decrease time and increase patient compliance. Compare typical children to those with Autism/communication delay. 2. Use icons during blood draw to improve communication with patients, to help with patient understanding, and increase patient cooperation and decrease noise and length of procedure.

Conditions Studied

Interventions

  • OTHER Icons

Study Locations (1)

Ohio

  • Akron Children's Hospital - Akron

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2011-02
Est. Completion 2011-02
Akron Children's Hospital

27 total trials

What the finished NCT01311596 record still lists

NCT01311596 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (55% lower).

The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Icons is the first listed.

NCT01311596 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT01311596 about?

NCT01311596 is a clinical study titled "Show Me to Help Me". This cohort observation, randomized controlled trial is intended to provide data that icons and non-verbal communication improve communication and cooperation with children with Autism/communication delay and aid in the transition to an unfamiliar environment. It would lay the foundation for future ...

What is the current status of trial NCT01311596?

This trial is currently completed. The enrollment target is 83 participants. The study started on 2011-02. Estimated completion is 2011-02.

What conditions does trial NCT01311596 study?

This clinical trial studies the following conditions: Autism.

What interventions are being tested in trial NCT01311596?

The interventions under investigation include: Icons (OTHER).

Who is sponsoring clinical trial NCT01311596?

This trial is sponsored by Akron Children's Hospital, which has 27 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01311596 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01311596's enrollment target sits among peer trials

83 43rd of 104 higher than 62 of 104 other Autism trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02974647 · 83 participants · Phase 2

    Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

  • NCT03919292 · 83 participants · Phase 1

    Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

  • NCT04626674 · 83 participants · Phase 1

    A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

  • NCT05277168 · 83 participants · Phase 1

    A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01311596, the US trial registry maintained by the National Library of Medicine. NCT01311596 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.